Stay updated with breaking news from Remunity Pump. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
United Therapeutics (NASDAQ:UTHR – Free Report) had its price objective raised by LADENBURG THALM/SH SH from $256.00 to $268.00 in a report released on Thursday morning, MarketBeat reports. They currently have a buy rating on the biotechnology company’s stock. Several other brokerages have also weighed in on UTHR. Argus cut their price target on United […]
United Therapeutics (NASDAQ:UTHR – Free Report) had its price target hoisted by Wedbush from $305.00 to $307.00 in a report published on Thursday morning, Benzinga reports. The firm currently has an outperform rating on the biotechnology company’s stock. A number of other analysts have also commented on UTHR. Argus cut their price objective on shares […]
United Therapeutics (NASDAQ:UTHR – Free Report) had its price target boosted by LADENBURG THALM/SH SH from $256.00 to $268.00 in a research report released on Thursday morning, MarketBeat Ratings reports. LADENBURG THALM/SH SH currently has a buy rating on the biotechnology company’s stock. Several other analysts have also recently commented on the stock. Morgan Stanley […]
United Therapeutics (NASDAQ:UTHR – Free Report) had its price objective upped by LADENBURG THALM/SH SH from $256.00 to $268.00 in a research note published on Thursday morning, MarketBeat Ratings reports. They currently have a buy rating on the biotechnology company’s stock. UTHR has been the subject of a number of other reports. Morgan Stanley decreased […]
Assetmark Inc. grew its holdings in shares of United Therapeutics Co. (NASDAQ:UTHR – Free Report) by 12.5% in the 1st quarter, according to its most recent disclosure with the SEC. The fund owned 270,423 shares of the biotechnology company’s stock after acquiring an additional 30,060 shares during the period. Assetmark Inc.’s holdings in United Therapeutics […]